Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.34% Nasdaq Up0.16%

BIOLASE, Inc. (BIOL)

-NasdaqCM

4.72 May 21, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 14,597   19,080   13,781   12,175  
Cost of Revenue8,803  10,190  7,500  6,675  
Gross Profit 5,794   8,890   6,281   5,500  
Operating Expenses
Research Development1,005  1,027  1,195  1,272  
Selling General and Administrative7,606  6,671  5,474  5,941  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,817) 1,192   (388) (1,713)
Income from Continuing Operations
Total Other Income/Expenses Net(99)(38)(28)(92)
Earnings Before Interest And Taxes(2,916)1,154  (416)(1,805)
Interest Expense87  99  98  38  
Income Before Tax(3,003)1,055  (514)(1,843)
Income Tax Expense(372)14  34  34  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,631)1,041  (548)(1,877)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (2,631) 1,041   (548) (1,877)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (2,631) 1,041   (548) (1,877)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.